Pharmacokinetics of Opicapone and Effect on COMT and Levodopa Pharmacokinetics in Patients with Parkinson's Disease

被引：0
|
作者：
Loewen, G. [1 ]
LeWitt, P. [2 ,3 ]
Olanow, C. W. [4 ]
Kieburtz, K. D. [5 ]
Liang, G. S. [1 ]
Jimenez, R. [1 ]
Olson, K. [1 ]
Roberts, E. [1 ]
机构：
[1] Neurocrine Biosci Inc, San Diego, CA USA
[2] Henry Ford Hosp, West Bloomfield, MI USA
[3] Wayne State Univ, Sch Med, Dept Neurol, West Bloomfield, MI USA
[4] Mt Sinai Sch Med, New York, NY USA
[5] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
来源：
MOVEMENT DISORDERS | 2019年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
18
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [11] Effect of gastrointestinal surgery on the pharmacokinetics of levodopa in Parkinson's disease
    Miyaue, N.
    Nomoto, M.
    Yabe, H.
    Yamanishi, Y.
    Tada, S.
    Ando, R.
    Kubo, M.
    Nagai, M.
    [J]. MOVEMENT DISORDERS, 2019, 34 : S142 - S142
  • [12] Effect of COMT inhibition on the pharmacokinetics and pharmacodynamics of levodopa in parkinsonian patients
    Nutt, JG
    [J]. NEUROLOGY, 2000, 55 (11) : S33 - S37
  • [13] The effect of co-administration of opicapone on the pharmacokinetics of levodopa
    Kamiyama, D.
    Nishikawa, N.
    Oyama, G.
    Hatano, T.
    Hattori, N.
    [J]. MOVEMENT DISORDERS, 2022, 37 : S454 - S454
  • [14] Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naive Patients With Parkinson's Disease
    Conti, Valeria
    Izzo, Viviana
    Russillo, Maria Claudia
    Picillo, Marina
    Amboni, Marianna
    Scaglione, Cesa L. M.
    Nicoletti, Alessandra
    Cani, Ilaria
    Cicero, Calogero E.
    De Bellis, Emanuela
    Charlier, Bruno
    Giudice, Valentina
    Somma, Gerardina
    Corbi, Graziamaria
    Barone, Paolo
    Filippelli, Amelia
    Pellecchia, Maria Teresa
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [15] Influence of ageing on the pharmacokinetics of levodopa in elderly patients with Parkinson's disease
    Nagayama, Hiroshi
    Ueda, Masayuki
    Kumagai, Tomoaki
    Tsukamoto, Kazuhisa
    Nishiyama, Yasuhiro
    Nishimura, Shungo
    Hamamoto, Makoto
    Katayama, Yasuo
    [J]. PARKINSONISM & RELATED DISORDERS, 2011, 17 (03) : 150 - 152
  • [16] The effect of ascorbic acid on the pharmacokinetics of levodopa in elderly patients with Parkinson disease
    Nagayama, H
    Hamamoto, M
    Ueda, M
    Nito, C
    Yamaguchi, H
    Katayama, L
    [J]. CLINICAL NEUROPHARMACOLOGY, 2004, 27 (06) : 270 - 273
  • [17] Population pharmacokinetics of levodopa in patients with Parkinson's disease treated with tolcapone
    Jorga, K
    Banken, L
    Fotteler, B
    Snell, P
    Steimer, JL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (06) : 610 - 620
  • [18] Levodopa Therapy for Parkinson's Disease: Pharmacokinetics and Pharmacodynamics
    LeWitt, Peter A.
    [J]. MOVEMENT DISORDERS, 2015, 30 (01) : 64 - 72
  • [19] The Pharmacokinetics and Pharmacodynamics of Levodopa in the Treatment of Parkinson's Disease
    Khor, Soo-Peang
    Hsu, Ann
    [J]. CURRENT CLINICAL PHARMACOLOGY, 2007, 2 (03): : 234 - 243
  • [20] Effect of opicapone multiple-dose regimens on levodopa pharmacokinetics, motor response, and erythrocyte-COMT activity in Parkinson's patients co-administered with levodopa/dopa-decarboxylase inhibitor
    Ferreira, J. J.
    Rocha, J. F.
    Falcao, A.
    Pinto, R.
    Nunes, T.
    Soares-da-Silva, P.
    [J]. MOVEMENT DISORDERS, 2013, 28 : S154 - S155
12345